Amphastar Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Amphastar Pharmaceuticals,

07/11/2022 22:02

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 38 cents​​ per share for the quarter ended
in September. The mean expectation of six analysts for the
quarter was for earnings of 39 cents per share.
    * Revenue rose 7.1% to $120.13 million from a year ago;
analysts
expected $126.37 million. 
    * Amphastar Pharmaceuticals Inc's reported EPS for the
quarter was
30 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Amphastar Pharmaceuticals Inc shares had risen by 5.9%
this
quarter and gained 27.8% so far this year.
    * The company reported quarterly net income of $15.87
million.
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $38.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.39           0.38           Missed
 Jun. 30 2022      0.35           0.39           Beat
 Mar. 31 2022      0.36           0.47           Beat
 Dec. 31 2021      0.36           0.42           Beat